
pmid: 16492533
An aqueous extract of Epilobium angustifolium and its main compound oenothein B (OeB), a dimeric macrocyclic ellagitannin, are specifically able to induce the neutral endopeptidase (NEP) in prostate cancer cells. The angiotensin-converting enzyme (ACE) is not influenced. Additionally, a weak but statistically significant inhibition of cell proliferation is observed. Simultaneous treatment of the cells with arabinosylcytosine and the extract as well as the OeB, leads to an additional enhancement of NEP activity. Taking into account the role of this peptidase in prostate cancer progression, our results might offer a pharmacological explanation for the use of Epilobium in folk medicine.
Male, Dose-Response Relationship, Drug, Plant Extracts, Cytarabine, Prostatic Neoplasms, Water, Dihydrotestosterone, Drug Synergism, Peptidyl-Dipeptidase A, Hydrolyzable Tannins, Cell Line, Tumor, Enzyme Induction, Humans, Neprilysin, Epilobium, Medicine, Traditional, Cell Proliferation, Phytotherapy
Male, Dose-Response Relationship, Drug, Plant Extracts, Cytarabine, Prostatic Neoplasms, Water, Dihydrotestosterone, Drug Synergism, Peptidyl-Dipeptidase A, Hydrolyzable Tannins, Cell Line, Tumor, Enzyme Induction, Humans, Neprilysin, Epilobium, Medicine, Traditional, Cell Proliferation, Phytotherapy
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 48 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
